Sign Up to like & get
recommendations!
0
Published in 2019 at "Investigational New Drugs"
DOI: 10.1007/s10637-019-00884-3
Abstract: Temozolomide is a first line anti-tumor drug used for the treatment of patients with Glioblastoma multiforme (GBM). However, the drug resistance to temozolomide limits its clinical application. Therefore, novel strategies to overcome chemoresistance are desperately…
read more here.
Keywords:
mrnas lncrnas;
glioblastoma;
lncrnas circrnas;
expression ... See more keywords